Analysis of: Health advocates warn government’s claims of baby formula safety contradict data
The Guardian | May 10, 2026
TL;DR
The FDA declares baby formula 'safe' while its own data shows over half contaminated with PFAS and phthalates. The state protects corporate profit over infant health, leaving parents to navigate toxic capitalism alone.
Analytical Focus:Class Analysis Contradictions Material Conditions
This story exposes a fundamental contradiction in capitalist governance: the state claims to protect public health while structurally serving the interests of capital accumulation. The FDA's declaration that baby formula 'meets a high safety standard' directly contradicts its own testing data showing over half of samples contaminated with PFAS and phthalates—chemicals the agency itself previously identified as dangerous at any level for infants. This is not merely bureaucratic incompetence but reflects the systematic subordination of regulatory agencies to corporate interests. The material conditions underlying this crisis reveal how the profit motive pervades every aspect of the food production process. Contamination originates from plastic packaging and processing equipment—cost-saving measures that externalize health costs onto consumers and future generations. The chemical industry's successful legal challenge against the EPA's attempted chlorpyrifos ban demonstrates how capital mobilizes legal and political power to protect profit over health. Meanwhile, the FDA claims it lacks authority to view industry's own testing data—a regulatory posture that privileges corporate secrecy over infant safety. The class dynamics are stark: formula manufacturers extract profit while externalizing health risks onto working-class families who depend on these products. The administration's response—declaring victory while withholding product names and refusing to set enforceable limits—serves capital by preventing meaningful accountability while providing ideological cover. Parents receive 'transparent data' without the ability to make informed choices, while industry faces no material consequences. This exemplifies how the capitalist state manages contradictions between accumulation and legitimation, offering rhetorical gestures toward protection while maintaining the conditions for continued exploitation.
Class Dynamics
Actors: Formula manufacturers (capitalist class), Chemical industry, FDA/regulatory agencies (state apparatus), Working-class parents and infants (consumers), Independent scientists and public health advocates, Trump administration officials
Beneficiaries: Formula manufacturers who avoid accountability, Chemical industry maintaining PFAS production, Plastics industry avoiding packaging regulations, Political officials claiming credit without action
Harmed Parties: Infants exposed to endocrine disruptors, Working-class families lacking alternatives to formula, Future generations bearing health consequences, Taxpayers who will fund healthcare for preventable conditions
The regulatory state operates as an instrument of class rule, managing contradictions between capital's need for accumulation and the requirement for social legitimacy. Industry wields legal and political power to block regulations (chlorpyrifos ban), maintain informational asymmetry (withholding test data), and escape accountability (no enforceable limits). Parents possess nominal 'consumer choice' but lack material power—they cannot opt out of the food system and receive data without actionable information. Independent scientists occupy a contradictory position: their expertise grants legitimacy to critique but lacks enforcement power.
Material Conditions
Economic Factors: Cost externalization through cheap plastic packaging, Profit-driven resistance to safer production methods, Legal costs of regulatory challenges as business expense, Healthcare costs shifted to families and public systems
The baby formula industry exemplifies capitalist commodity production where use-value (infant nutrition) is subordinated to exchange-value (profit extraction). Contamination is not accidental but structural—plastic processing equipment and packaging are chosen for cost efficiency, not safety. The relations of production mean workers in formula plants have no control over ingredients or safety protocols, while consumers have no input into production decisions. The FDA's position—claiming lack of authority to view industry data—reveals how intellectual property and corporate secrecy are embedded in production relations, protecting profit margins over public health.
Resources at Stake: Infant health and development, Corporate profit margins in $4+ billion US formula market, Chemical industry's continued PFAS production, Regulatory agency legitimacy, Political capital for administration officials
Historical Context
Precedents: Lead paint industry's decades-long denial of health risks, Tobacco industry's suppression of cancer research, 2008 melamine contamination scandal in Chinese formula, 2022 Abbott formula recall and shortage crisis, Flint water crisis demonstrating regulatory failure
This case exemplifies the neoliberal regulatory model that emerged since the 1980s: agencies are captured by industries they regulate, enforcement is replaced by voluntary compliance, and public health is subordinated to market imperatives. The pattern of industry-funded legal challenges blocking regulation (chlorpyrifos) reflects capital's systematic investment in dismantling protective legislation. The FDA's expanded testing represents a contradictory response—providing data while refusing enforceable standards—characteristic of how the neoliberal state manages legitimation crises through symbolic action. California and Vermont's proposed transparency legislation demonstrates how contradictions open space for reform struggles at the state level.
Contradictions
Primary: The fundamental contradiction between the state's claimed function (protecting public health) and its structural role (facilitating capital accumulation). The FDA simultaneously produces damning data and declares products safe, exposing how regulatory agencies serve accumulation while managing legitimacy through performance of oversight.
Secondary: Contradiction between Kennedy's 'Make America Healthy Again' rhetoric and serving industry interests, Tension between transparency (releasing data) and concealment (withholding product names), Conflict between scientific consensus (no safe level of endocrine disruptors) and regulatory inaction, Contradiction between parental 'choice' ideology and material impossibility of opting out
Short-term: The administration will likely continue symbolic gestures while avoiding binding regulation. The state-level legislation in California and Vermont represents reformist pressure that may force limited concessions. Medium-term: Absent organized pressure from below, the contradiction will be managed through incremental 'improvements' that maintain the fundamental structure. Long-term: Resolution requires either working-class political organization capable of subordinating production to social need, or deepening health crises that delegitimize the regulatory apparatus entirely.
Global Interconnections
This crisis connects to global patterns of environmental injustice under capitalism. PFAS contamination is not confined to baby formula but pervades water systems, food production, and consumer goods worldwide—the article's reference to ICE facilities on PFAS-contaminated sites reveals how toxic exposure maps onto existing structures of racial and class oppression. The 'widespread use of PFAS' that produces this contamination reflects global supply chains organized around profit maximization, where chemical companies externalize costs across borders and generations. The formula industry's structure—dominated by a few multinational corporations operating across regulatory jurisdictions—demonstrates how monopoly capitalism enables regulatory arbitrage. Companies can threaten to relocate production, creating a race to the bottom in safety standards. The 2022 Abbott shortage crisis revealed supply chain vulnerabilities that increase working-class dependence on whatever products are available, reducing consumer power further. Meanwhile, the chemical industry's global reach means that even domestic regulations face challenges from international trade frameworks that privilege capital mobility over health protection.
Conclusion
This case illuminates how capitalist production systematically poisons the most vulnerable while the state provides ideological cover rather than material protection. For working-class families, the lesson is not that better consumer choices can navigate this system—the absence of product names ensures that's impossible—but that the structure itself produces harm. Meaningful change requires organizing that challenges both the chemical industry's power and the captured regulatory apparatus. The independent scientists and advocates quoted here represent one form of resistance, but their critique lacks enforcement power without mass political organization. State-level legislation offers reformist terrain for struggle, but the fundamental contradiction—between production for profit and production for human need—cannot be resolved within capitalism's framework. The contamination of infant formula is not a policy failure to be corrected but a systemic feature to be abolished.
Suggested Reading
- The State and Revolution by V.I. Lenin (1917) Lenin's analysis of the capitalist state as an instrument of class rule illuminates how regulatory agencies like the FDA serve capital's interests while maintaining ideological legitimacy through performance of public protection.
- The Shock Doctrine by Naomi Klein (2007) Klein's examination of how crises are exploited to advance corporate interests helps explain the administration's strategy of using health concerns to claim action while protecting industry from accountability.
- Capital, Volume 1 by Karl Marx (1867) Marx's analysis of how capitalism externalizes costs onto workers and society explains the structural logic behind choosing cheap contaminating materials over safe alternatives in production.